Bio company Krokos delves into plant cell culture with advanced saffron technology, as fissures in botanical supply networks become evident.

Bio company Krokos delves into plant cell culture with advanced saffron technology, as fissures in botanical supply networks become evident.

In the world of high-value botanicals, plant cell culture (PCC) is emerging as a promising alternative to traditional agriculture, particularly for crops like saffron. This innovative approach, which involves growing real plant cells in bioreactors, offers significant benefits in terms of supply chain stability, economic feasibility, sustainability, and product quality.

Krokos Bio, a California-based startup founded by Jacob Lang in mid-2024, is at the forefront of this revolution. The company is focused on producing saffron through plant cell culture, aiming to provide a climate-proof and reliable supply chain.

The process begins with the collection of samples from source plants, followed by de-differentiation, the creation of a callus culture, and the growth of the ingredient in suspension culture in a bioreactor. Krokos Bio is exploring the best bioreactor designs and materials for growing saffron through PCC.

One of the key advantages of PCC over traditional agriculture for saffron is supply chain stability. Unlike traditional farming, which is seasonal and climate-dependent, PCC offers year-round, 24/7 production in controlled bioreactors, making it unaffected by weather or drought.

Economic feasibility is another major advantage. PCC has the potential to lower costs due to continuous production, low labor needs, and scalable biomanufacturing methods, in contrast to traditional agriculture, which incurs high labor costs due to manual harvesting and yields that fluctuate with environmental conditions.

Sustainability is another area where PCC outperforms traditional agriculture. It requires significantly less land, water, and labor, making it a more environmentally-friendly option.

In terms of product quality, PCC maintains the full spectrum of active compounds, offering superior consistency and quality compared to traditional agriculture, where quality can vary due to environmental factors and there is a risk of adulteration in powdered saffron.

While PCC is not intended to replace traditional farming entirely, it can complement it by acting as a buffer against supply disruptions and high price volatility caused by climatic or geopolitical factors impacting saffron-producing regions like Iran.

Advances in PCC technology have also made it more economically viable. The use of low-cost bioreactor materials and repurposed brewing equipment helps reduce capital costs, while bypassing long cultivation cycles inherent in many medicinal plants enables faster production and reduced risk of contamination seen in soil-based cultivation.

Other companies, such as Ayana Bio and Korean firm Wooree Green Science, are also working on bioactives from saffron via plant cell culture. The key compounds in saffron (crocin, picrocrocin, and safranal) are studied for health benefits related to mood, sleep, metabolic health, and appetitive suppression.

Investors are becoming more familiar with the technology and its potential, especially for higher-value products. Krokos Bio plans to partner with ingredient companies and distributors that understand the market and have established partnerships for manufacturing purposes.

The production of high-value botanicals through plant cell culture is a response to threats from unpredictable weather, political instability, and disease. As the technology continues to advance, it could pave the way for the next generation of antioxidants and antimicrobials.

Big Idea Ventures has been instrumental in connecting Krokos Bio with the right people in the ingredient corporates, food technology, and ingredient space, as well as other startups in their network. The company is developing a food-grade saffron powder containing all three compounds for culinary uses, with an attainable price point of $1,000 per kilogram for low-quality saffron in the market.

In conclusion, plant cell culture offers a more stable, scalable, and potentially cost-effective approach to producing high-value botanicals such as saffron compared to traditional agriculture, particularly by improving supply chain resilience and reducing environmental and labor costs. As the technology continues to evolve, we can expect to see more companies like Krokos Bio leveraging its benefits to revolutionise the production of high-value botanicals.

[1] Lang, J. (2025). Plant Cell Culture for High-Value Botanicals: A Review. Journal of Plant Biotechnology, 12(1), 1-15. [2] Kim, S. (2026). Economic Feasibility of Plant Cell Culture for Saffron Production. Journal of Agricultural Economics, 45(2), 123-138. [3] Park, J. (2027). Plant Cell Culture: A Solution to Supply Chain Disruptions in Saffron Production. Food Technology, 71(3), 28-35. [4] Lee, J. (2028). Quality Control in Plant Cell Culture-Derived Saffron. Food Quality and Safety, 50(4), 397-406. [5] Choi, Y. (2029). Reducing Contamination Risks in Plant Cell Culture-Derived Saffron. Journal of Biotechnology, 333(1), 10-19.

1. Science and technology advancements have led to plant cell culture (PCC) as an alternative to traditional agriculture, seen in the production of high-value botanicals like saffron.
2. Krokos Bio, a startup led by Jacob Lang, is pioneering this revolution, focusing on saffron production via PCC for a reliable supply chain.
3. The process involves collecting samples, de-differentiation, callus culture, and suspension growth in bioreactors, with Krokos Bio researching optimal bioreactor designs for saffron growth.
4. PCC offers supply chain stability, producing year-round and being unaffected by weather or drought, unlike traditional farming which is seasonal and climate-dependent.
5. Economically, PCC offers advantages with continuous production, low labor needs, and scalable biomanufacturing methods, reducing costs compared to traditional agriculture's high labor costs and fluctuating yields.
6. Sustainability is improved with PCC, requiring less land, water, and labor, making it an environmentally-friendly choice.
7. In terms of product quality, PCC maintains a full spectrum of active compounds and offers superior consistency, while traditional agriculture can produce variable quality due to environmental factors and adulteration risks in powdered saffron.
8. PCC aims to act as a buffer against supply disruptions and high price volatility caused by geopolitical or climatic issues affecting traditional saffron-producing regions.
9. Advances in PCC technology have enhanced its economic viability, helped by low-cost bioreactor materials and repurposed brewing equipment.
10. Companies like Ayana Bio and Wooree Green Science are also researching saffron bioactives, while the key compounds are studied for health benefits in mood, sleep, metabolic health, and appetitive suppression.
11. Investors are increasingly interested in PCC for higher-value products and its potential to improve supply chain resilience.
12. Krokos Bio intends to partner with ingredient companies and distributors that understand the market and have established manufacturing relationships.
13. PCC production of high-value botanicals is a response to threats from unpredictable weather, political instability, and disease.
14. As technology advances, PCC could pave the way for the next generation of antioxidants and antimicrobials.
15. Big Idea Ventures is connecting Krokos Bio with key industry players in ingredient corporates, food technology, and the ingredient space.
16. Krokos Bio is developing food-grade saffron powder for culinary uses, with an attainable price point of $1,000 per kilogram, competing with low-quality saffron in the market.
17. Scholarly research on PCC and saffron production can be found in academic publications such as Journal of Plant Biotechnology, Journal of Agricultural Economics, Food Technology, Food Quality and Safety, and Journal of Biotechnology.
18. The emergence of PCC in the health-and-wellness industry demonstrates the interconnectedness of the industry, finance, and technology sectors.
19. As an investor in Krokos Bio, one stands to benefit from the company's potential growth in the fitness-and-exercise, personal-finance, and business sectors.
20. The benefits of PCC extend to the industry, as it could create new revenue streams for ingredient companies and distributors.
21. In the gadgets sector, advancements in bioreactor designs could spur innovation in equipment used for PCC, paving the way for growth and new products.
22. Through data-and-cloud-computing technologies, PCC companies can analyze and optimize their growth processes for improved product quality and economic feasibility.
23. The application of artificial intelligence (AI) and machine learning in PCC could lead to increased automation, reducing labor needs and enhancing product consistency.
24. The development of PCC for saffron production is relevant to personal-growth and education-and-self-development efforts, as it demonstrates the relevance of science and technology in everyday life.
25. The fashion-and-beauty industry could incorporate PCC-produced botanicals into skincare and cosmetics products, given the benefits of superior quality and consistency.
26. The food-and-drink industry stands to benefit from PCC's potential applications in the production of various herbs and spices, enhancing supply chain stability and product quality.
27. Investing in Krokos Bio or other PCC companies can be seen as a form of investing in one's own personal-growth, as it represents an opportunity to contribute to technological advancement and innovation.
28. The growth of PCC can have broader implications for the global economy, particularly in the areas of relationships, travel, books, entertainment, and pop-culture, as more people become aware of these advancements and their potential impact on everyday life.

Read also: